Corticosteroid Injection in Carpal Tunnel Syndrome
Comparison of Different Dose of Steroid Injection in Carpal Tunnel Syndrome
1 other identifier
interventional
56
1 country
1
Brief Summary
To compare the effectiveness of different dose of ultrasound guided steroid injection in patient with carpal tunnel syndrome, by using clinical and electrophysiological parameters in evlauation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2017
CompletedFirst Submitted
Initial submission to the registry
March 1, 2017
CompletedFirst Posted
Study publicly available on registry
March 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 28, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2018
CompletedJuly 30, 2019
July 1, 2019
1.8 years
March 1, 2017
July 28, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change from Baseline in the scores on the Boston Carpal Tunnel Questionnaire (BQ).
The BQ was interviewed-administered to assess the severity of symptoms and functional status.
at 6, 12 weeks
Secondary Outcomes (4)
Change from Baseline in Median nerve distal motor latency
at 6, 12 weeks
Change from Baseline in sensory nerve conduction velocity
at 6, 12 weeks
Change from Baseline in compound muscle action potential amplitude (CMAP)
at 6, 12 weeks
Change from Baseline in self-reported pain intensity
at 6, 12 weeks
Study Arms (2)
low dose steroid
EXPERIMENTALultrasound-guided steroid injection using 1ml of 10 mg (10mg/ml) triamcinolone acetonide (Shincort) mixed with 1 ml of 2% lidocaine hydrochloride (Xylocaine)
comparator
ACTIVE COMPARATORultrasound-guided steroid injection using 1ml of 40 mg (40mg/ml) triamcinolone acetonide (Shincort) mixed with 1 ml of 2% lidocaine hydrochloride (Xylocaine)
Interventions
ultrasound-guided injection using 1ml of 10 mg (10mg/ml) or 40 mg (40 mg/ml) triamcinolone acetonide (Shincort)
ultrasound-guided injection using 1 ml of 2% lidocaine hydrochloride (Xylocaine)
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of CTS
- The diagnosis of CTS was confirmed by electrophysiological tests.
You may not qualify if:
- presence of thenar atrophy
- existence of disorders such as hypothyroidism, diabetes mellitus, chronic renal failure, or rheumatoid arthritis; any accompanying orthopedic or neurologic disorders that could mimic CTS such as cervical radiculopathy, polyneuropathy, proximal median nerve entrapment, or thoracic outlet syndrome
- prior steroid injection into the affected carpal tunnel within 6 months or ever received carpal tunnel surgery
- history of distal radius fracture
- pregnancy or lactation
- regular use of systemic NSAIDs ,corticosteroids or diuretics
- known allergy to corticosteroids and local anesthetics.
- impaired cognitive function
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taipei veteran general hospital
Taipei, Taiwan
Related Publications (1)
Hsu PC, Liao KK, Lin KP, Chiu JW, Wu PY, Chou CL, Wang NY, Wang JC. Comparison of Corticosteroid Injection Dosages in Mild to Moderate Idiopathic Carpal Tunnel Syndrome: A Randomized Controlled Trial. Arch Phys Med Rehabil. 2020 Nov;101(11):1857-1864. doi: 10.1016/j.apmr.2020.06.018. Epub 2020 Jul 16.
PMID: 32682938DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 1, 2017
First Posted
March 7, 2017
Study Start
February 18, 2017
Primary Completion
November 28, 2018
Study Completion
December 20, 2018
Last Updated
July 30, 2019
Record last verified: 2019-07